These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14741112)

  • 1. Closed-loop insulin delivery-the path to physiological glucose control.
    Steil GM; Panteleon AE; Rebrin K
    Adv Drug Deliv Rev; 2004 Feb; 56(2):125-44. PubMed ID: 14741112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with an implanted closed-loop insulin delivery system.
    Renard E
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):349-54. PubMed ID: 18438546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
    Uduku C; Oliver N
    Curr Opin Pharmacol; 2017 Oct; 36():29-33. PubMed ID: 28802779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of glucose-responsive 'smart' insulin systems.
    Rege NK; Phillips NFB; Weiss MA
    Curr Opin Endocrinol Diabetes Obes; 2017 Aug; 24(4):267-278. PubMed ID: 28509691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.
    Young AJ; Thabit H; Heller SR; Evans ML; Amiel SA; Hovorka R; Barnard KD
    J Diabetes Sci Technol; 2015 Jul; 9(4):932-3. PubMed ID: 25852073
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and closed-loop insulin delivery.
    Adams G; Clark J; Sahota T; Tanna S; Taylor MJ
    Biotechnol Genet Eng Rev; 2000; 17():455-96. PubMed ID: 11255678
    [No Abstract]   [Full Text] [Related]  

  • 13. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.
    Renard E; Costalat G; Chevassus H; Bringer J
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):497-502. PubMed ID: 17130808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioartificial pancreas to prevent diabetic microangiopathy?
    Reach G; Chicheportiche D; Moussy F; Darquy S
    Contrib Nephrol; 1990; 78():157-64; discussion 165. PubMed ID: 2225831
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances toward the implantable artificial pancreas for treatment of diabetes.
    Jaremko J; Rorstad O
    Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can technological solutions for diabetes replace islet cell function?
    Gregory JM; Moore DJ
    Organogenesis; 2011; 7(1):32-41. PubMed ID: 21289480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2014 Jun; 11(6):943-55. PubMed ID: 24749563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis.
    Steil GM; Rebrin K; Janowski R; Darwin C; Saad MF
    Diabetes Technol Ther; 2003; 5(6):953-64. PubMed ID: 14709197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.